Concepedia

Haiyuan Zhu

HZ

Statistics

Publications

13

Citations

865

H-Index

12

Active since

2002

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Allergan (United States)

Indiana University School of Medicine

University of Liverpool

Indiana University – Purdue University Indianapolis

Haiyuan Zhu is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacotherapy, and pharmacology.

Top concepts

Publications per year

2002–2024

13

Publications

13

Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial

Inder Kaul, Sharon Sawchak, Christoph U. Correll et al. · The Lancet · 2023 · 192 citations

, , +9

Efficacy and Safety of Intranasal Peptide YY3–36 for Weight Reduction in Obese Adults

Ira Gantz, Ngozi Erondu, Madhuja Mallick et al. · The Journal of Clinical Endocrinology & Metabolism · 2007 · 160 citations · Full text

Efficacy and Safety of Xanomeline-Trospium Chloride in Schizophrenia

Inder Kaul, Sharon Sawchak, David P. Walling et al. · JAMA Psychiatry · 2024 · 132 citations · Full text

Sample size calculation for comparing two negative binomial rates

Haiyuan Zhu, Hassan Lakkis · Statistics in Medicine · 2013 · 102 citations

Cardiovascular Safety in Patients Receiving Roflumilast for the Treatment of COPD

William B. White, Glen E. Cooke, Peter R. Kowey et al. · CHEST Journal · 2013 · 98 citations

, , +8

1–5 of 13